▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Tandem Diabetes Care (NASDAQ: TNDM)

$22.86

(0.6%)

$0.13

Price as of May 20, 2025, 10:36 a.m. ET

Tandem Diabetes Care Return vs. S&P

	1 Year	5 Year	5 Year Annualized	Since IPO
TNDM	-51.95%	-73.31%	-23.22%	-88%
S&P	+12.45%	+100.69%	+14.95%	+233%

Tandem Diabetes Care Company Info

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.

News & Analysis

The Fool has written over 100 articles on Tandem Diabetes Care.

Featured Article

Why Tandem Diabetes Care Stock Took It on the Chin Tuesday

Flat revenue growth might be in store for the company in a very crucial market.

Eric Volkman | Oct 1, 2024

Featured Article

Why Tandem Diabetes Care Stock Thrashed the Market Today

At a stroke, it's got a product authorized for a specific use in 27 countries.

Eric Volkman | Sep 19, 2024

Why Tandem Diabetes Stock Just Jumped 22%

Rich Smith | May 3, 2024

Tandem Diabetes stock is showing great growth -- but miserable profits.

1 Beaten-Down Stock That Could Make You Richer

Prosper Junior Bakiny | Apr 7, 2024

Don't give up on this healthcare stock too soon.

Why Tandem Diabetes Care Stock Was Zooming Higher Today

Eric Volkman | Mar 26, 2024

One product in particular could juice the company's fundamentals, a pundit believes.

Why Tandem Diabetes Care Stock Popped Today

Steve Symington | Feb 22, 2024

Tandem Diabetes climbed as investors focused on its strong outlook for the coming year.

2 Beaten-Down Stocks That Are Worth Buying

Prosper Junior Bakiny | Feb 4, 2024

Don't be too quick to ignore these stocks.

2 Stocks Under $25 to Buy and Hold for 10 Years

Prosper Junior Bakiny | Sep 29, 2023

There's no need to break the bank to get in on the action.

Valuation

Podcast Episodes

20190501_IF_Healthcare_thumb

Who Had the Better Quarter, Tandem Diabetes or Teladoc?

These two disruptive companies reported crazy-good top-line growth, but only one can be the winner.

Todd Campbell | May 3, 2019

Earnings Transcripts

Tandem Diabetes Care, inc (TNDM) Q3 2021 Earnings Call Transcript

TNDM earnings call for the period ending September 30, 2021.

Motley Fool Transcribers | Nov 3, 2021

Tandem Diabetes Care, inc (TNDM) Q2 2021 Earnings Call Transcript

TNDM earnings call for the period ending June 30, 2021.

Motley Fool Transcribers | Aug 5, 2021

Tandem Diabetes Care Inc (TNDM) Q1 2021 Earnings Call Transcript

TNDM earnings call for the period ending March 31, 2021.

Motley Fool Transcribers | May 6, 2021

Tandem Diabetes Care Inc (TNDM) Q4 2020 Earnings Call Transcript

TNDM earnings call for the period ending December 31, 2020.

Motley Fool Transcribers | Feb 24, 2021

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services